bpc-157 human clinical trials rct Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing Peptide Injections vs. Platelet-Rich Plasma
Description
doi: 10.1038/nature23469
Batt RM, et al
Still within the 100-unit syringe range, but just barely
The first responders who get the best results are the ones who use peptides as part of an overall health strategynot as a replacement for taking care of themselves
Patients induced with rituximab with good tolerability can be considered for the maintenance phase with rituximab [67]
